. Author manuscript; available in PMC: 2013 Jul 1.

Published in final edited form as: Int Immunopharmacol. 2012 May 16;13(3):322–330. doi: 10.1016/j.intimp.2012.05.004

Table I.

Summary of significant differences in absolute numbers of cell populations between the 4NQO control group and the DCnt and DCpm-vaccinated groups.

4 Weeks
Absolute # (compared to 4NQO Control)	Tconv		Treg	Activated Tconv		Th1/Tc1		Th17/Tc17		Th2
Absolute # (compared to 4NQO Control)	CD4⁺ Foxp3⁻	CD8⁺ Foxp3⁻	CD4⁺ Foxp3⁺	CD25⁺ CD4 Tconv	CD44^hi CD4 Tconv	CD4⁺ IFN-γ⁺	CD8⁺ IFN-γ⁺	CD4⁺ IL-17A⁺	CD8⁺ IL-17A⁺	CD4⁺ IL-10⁺
DCnt	↑	↑	↑	↑	↑	↑	↑	↑	↑	↑
DCpm

8 Weeks
Absolute # (compared to 4NQO Control)	Tconv	Treg		Activated Tconv			Tc1	Th17/Tc17		Th2
Absolute # (compared to 4NQO Control)	CD8⁺ Foxp3⁻	CD4⁺ Foxp3⁺	CD8⁺ Foxp3⁺	CD25⁺ CD8 Tconv	CD44^hi CD4 Tconv	CD44^hi CD8 Tconv	CD8⁺ IFN-γ⁺	CD4⁺ IL-17A⁺	CD8⁺ IL-17A⁺	CD4⁺ IL-4⁺	CD4⁺ IL-13⁺
DCnt	↑	↑	↑	↑		↑	↑	↑	↑		↑
DCpm	↑	↑		↑	↑	↑	↑	↑	↑	↑	↑